Therefore, PPAR-α agonists, which are primarily divided into synthetic fibrates and natural occurring agonists, are extensively used in the treatment of obesity, diabetes, and inflammatory diseases [49]. The gene discussed is PPARA; the disease is obesity due to melanocortin 4 receptor deficiency.